Although IFNβ plays an essential antiviral role in COVID-19 by limiting SARS-CoV-2 propagation, a sustained increase in its expression is associated with aberrant inflammation and poor clinical outcomes39. The gene discussed is IFNB1; the disease is COVID-19.